Dr. Stephen Hahn, one of the frontrunners for the top FDA position, has been in the middle and on the fringes of multiple high-profile controversies throughout his career. But what they've revealed is a knack for operating within highly rigid and institutionalized environments, his supporters say.
from Kaiser Health News https://ift.tt/2N5v1DO
September 10, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘It’s Time For Big Pharma To Pay For What They’ve Done’: NYC Mayor Sues Companies Over Opioid CrisisMayor Bill de Blasio is just the latest state official to try to fight the epidemic through the court system. from Kaiser Health News http://ift.tt/2E3p2YC … Read More
Activist Shareholders Granted More Power As Tenet Changes Its BylawsThe county's third-largest investor-owned hospital company is allowing its shareholders to call meetings. The move is part of a broader trend in the industry to give more control to shareholders. from Kaiser Health News http… Read More
Hospital, Physician Groups Wary But Curious About CMS’ Bundled-Pay ModelUnder the initiative, organizations enter into payment arrangements that include financial and performance accountability for episodes of care. from Kaiser Health News http://ift.tt/2E4dUuF … Read More
First Edition: January 24, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News http://ift.tt/2E4mHMZ … Read More
Drugmakers Have ‘Tremendous Potential’ In War Against Superbugs, But They’re Not Doing EnoughA new report finds that those in the pharmaceutical industry are making progress in the fight against superbugs, but "every company can do more." from Kaiser Health News http://ift.tt/2DtNelX … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment